FTC tells Novartis to divest 4 skin care drugs – Businessweek

Novartis is also being ordered to return the rights to diclofenac sodium, a treatment for actinic keratosis. Shares of Novartis rose 35 cents to $56.12 in afternoon trading.

Leave a Reply

Your email address will not be published.

*